SynthesisParasitology research2025
Exploring real-time PCR techniques for diagnosing leishmaniasis: key insights from a systematic review.
Synthesis in Parasitology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Evaluation of a commercial real-time PCR assay targeting Leishmania spp. with microscopically positive skin biopsies obtained from Nigerian patients.European journal of microbiology & immunology · 2026Article
- Molecular Diagnosis of Leishmaniasis: Development of a qPCR Assay for Genus Detection and Differentiation ofDiagnostics (Basel, Switzerland) · 2026Article
- Analytical and clinical performance of in-house and commercial real-time PCR assays for diagnosingJournal of clinical microbiology · 2026Article
- Comparative quantification of Leishmania infantum in experimental phlebotomine sand fly infections using kDNA and single-copy Meta-1 gene qPCR assays.Parasites & vectors · 2026Article
- Autochthonous canine cutaneous leishmaniasis caused byCurrent research in parasitology & vector-borne diseases · 2026Article
- Molecular diagnostics for cutaneous leishmaniasis: progress towards fulfilling the WHO target product profile.Parasitology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Real-time PCR (qPCR) has emerged as a promising alternative to be used in the diagnosis of leishmaniasis. However, a consensus on the standardized approach for this purpose is yet to be established. This systematic review aims to highlight relevant aspects for the development of possible consensus protocols. The study included publications from January 2011 to July 2023 using different databases. Studies focusing on qPCR standardization for the diagnosis of leishmaniasis were included. The collected data encompassed study group details, geographical locations, sample types and quantities, molecular targets, and qPCR methodologies, which were subsequently pooled and analyzed. Forty-three studies conducted in diverse regions of the world were included. The majority were visceral leishmaniasis, followed by cutaneous leishmaniasis and post-kala-azar dermal leishmaniasis. Overall, invasive samples demonstrated higher sensitivity (> 90%) compared to non-invasive samples (< 90%), but both exhibited high specificity (> 85%). Furthermore, the kDNA minicircle was identified as the most promising molecular target, with a discreet preference for the use of TaqMan probes over SYBR Green. Various qPCR approaches have exhibited promising results in the diagnosis of leishmaniasis. However, further studies exploring non-invasive sampling techniques in conjunction with appropriate molecular targets are essential to establish efficient and reliable diagnostic techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.